GlobeNews Wire

Avicanna Announces Change in CFO

September 12, 2025 18:00 ET  | Source: Avicanna Inc. TORONTO, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Avicanna Inc. (“Avicanna” or…

10 months ago

Update on Information Relating to the General Meeting of September 30, 2025

Update on Information Relating to the General Meeting of September 30, 2025 61 Founding, Historical, Employee and Executive Shareholders of…

10 months ago

Save the Date: HUTCHMED to Present R&D Updates on October 31, 2025

— HUTCHMED will host in-person presentation and online webinar on Friday, October 31 — September 11, 2025 20:00 ET  |…

10 months ago

Achieve Life Sciences Names Dr. Mark Rubinstein Interim Chief Medical Officer

September 11, 2025 17:01 ET  | Source: Achieve Life Sciences SEATTLE and VANCOUVER, British Columbia, Sept. 11, 2025 (GLOBE NEWSWIRE)…

10 months ago

Armstrong Asia Signs MOU with Checkmate Capital Group to Explore Strategic Collaboration

SINGAPORE, Sept. 12, 2025 (GLOBE NEWSWIRE) -- Armstrong Asia, a leading Singapore-based manufacturer of flexible material solutions with 16 factories…

10 months ago

Cloudera Recognized as a Leader in the IDC APAC MarketScape for Unified AI Platforms 2025 Vendor Assessment

This recognition highlights the company’s strength in governance, security, and innovation September 11, 2025 21:00 ET  | Source: Cloudera, Inc.…

10 months ago

Correction: Next Technology Holding Inc. Announces Reverse Stock Split

September 11, 2025 18:55 ET  | Source: Next Technology Holding Inc. CHEYENNE, Wyoming, Sept. 11, 2025 (GLOBE NEWSWIRE) -- Next…

10 months ago

GenVivo Strengthens Oncology Leadership with Appointment of Noriyuki Kasahara, M.D., Ph.D., as Chief Scientific Officer

Scientific Advisory Board member, Dr. Noriyuki Kasahara, appointed Chief Scientific Officer of GenVivo, to accelerate the achievement of major clinical…

10 months ago

RadioMedix and Vect-Horus Announce First Patient Dosed in Exploratory Clinical Study of 203Pb-RMX-VH-PIB for Glioblastoma Multiforme and Pancreatic Ductal Adenocarcinoma

Marks a significant milestone in ongoing collaboration between RadioMedix and Vect-Horus to advance innovative Theranostic radiopharmaceuticals to address unmet needs…

10 months ago

Bioxodes positive Phase 2a stroke data show breakthrough potential of innovative therapeutic candidate BIOX-101

Safety endpoint met, with encouraging signs of efficacy in trial with 23 patients suffering from intracerebral hemorrhage (ICH)Findings suggest BIOX-101…

10 months ago